Institutional investors purchased a net $2.2 million shares of GENE during the quarter ended December 2016 and now own 16.91% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 1.1 Million shares of Genetic Technologies Ltd
HEIGHTS CAPITAL MANAGEMENT, INC. Bought 923.4 Thousand shares of Genetic Technologies Ltd